Impact of Biologic and Immunomodulatory Therapy on SARS-CoV-2 Infection and Immunity in Patients with Inflammatory Bowel Disease
CLARITY IBD at a Glance
CLARITY IBD is a COVID-19 urgent public health research study supported by the UK NIHR. We are aiming to understand the impact of inflammatory bowel disease treatments and physical distancing strategies on COVID-19 through the use of serology testing. We aim to recruit almost 7000 patients from around the UK
"Act as if what you do makes a difference. It does"
William James
CLARITY IBD
Exeter IBD Research Group
Royal Devon & Exeter NHS Foundation Trust
Barrack Road
Exeter EX2 5DW
+44 (0)1392 406850